Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2017 | Cancer diagnosis and survival in the UK

Graeme Betts • 6 Oct 2017
BOPA 2017
General

The early diagnosis of cancer is key to survival; however, with the many demands upon the NHS this can be challenging. In this interview, Graeme Betts from the Regional Manager Health Professional Engagement Programme, Cancer Research UK, UK discusses the current landscape of cancer diagnosis and survival. Topical points covered include the survival rates of cancer patients in the UK vs. other developed nations, and the aims of CRUK in terms of cancer diagnosis and survival rates. This video was recorded at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK.

More from Graeme Betts

1:22
The CRUK Facilitator programme: from the lab to the clinic
Graeme Betts • 6 Oct 2017

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals